The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStar Energy Regulatory News (STAR)

Share Price Information for Star Energy (STAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.925
Bid: 9.60
Ask: 10.25
Change: 0.00 (0.00%)
Spread: 0.65 (6.771%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.925
STAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

18 Apr 2019 07:00

RNS Number : 5557W
Starcom PLC
18 April 2019
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). In addition, market soundings were taken in respect of the matters contained in this announcement, with the result that certain persons became aware of such inside information. Upon the publication of this announcement, this inside information is now considered to be in the public domain and such persons shall therefore no longer in possession of inside information relating to the Company and its securities. 

 

18 April 2019

 

Starcom Plc

("Starcom" or the "Company")

 

Issue of equity

 

Starcom (AIM: STAR), which specialises in the development of wireless solutions for the remote tracking, monitoring and protection of a variety of assets, is pleased to announce that the Company has conditionally raised £637,500 before expenses through a subscription of 51,000,000 new Ordinary Shares of no par value (the "Subscription Shares") at a price of 1.25 pence per Subscription Share, (the "Subscription"). The Subscription is being undertaken utilising the Company's existing share authorities and has been subscribed for by a combination of new and existing shareholders. 

 

The net proceeds of the Subscription will be used to pay suppliers in order to satisfy further demand for the Company's products, including the new Lokies padlock, details of which were announced on 5 April 2019. In addition, the Company intends to use the net proceeds of the Subscription to intensify its marketing and sales effort and for general working capital purposes. The Directors consider that undertaking an equity raise of this size at this stage will place the Company in a better financial position to pursue its strategy and, at the same time, avoid the requirement for more frequent capital raises that it has made in the past.

 

In addition to the Subscription and in an attempt to conserve the Company's cash position, the Directors are proposing to receive Ordinary Shares and/or options in lieu of historic unpaid director salaries and future fees as they fall. The details of these proposals are still to be finalised by the Board and any such proposals would be made subject to shareholder approval at a general meeting of the Company. Further announcements will be made in due course.

 

Proposed board appointment

 

The Company is pleased to announce its intention to appoint Martin Blair as non-executive director of the Company, subject to satisfactory completion of customary due diligence by its nominated adviser, in accordance with the AIM Rules. Martin Blair is a highly experienced director within the software, life sciences and media industries and is currently a director of Kape PLC, Cakebox Holdings plc and Green Biologics Ltd. Further updates will be made in due course.

 

Application for Admission

 

Application has been made for the Subscription Shares, which will rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is anticipated that Admission will become effective at 8.00 a.m. on 24 April 2019. 

 

Total voting rights 

 

On Admission, the Company's enlarged issued share capital will comprise 344,449,513 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 344,449,513. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

Michael Rosenberg, Chairman of Starcom commented, "These new funds will enable the Company to pursue a more aggressive marketing strategy as we are promoting our new range of tracking and monitoring products, to take advantage of the positive responses we are receiving from existing and potential clients and to leverage our position as one of the world leaders in our technological market place."

 

Information for Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the Product Governance Requirements) may otherwise have with respect thereto, the Subscription Shares have been subject to a product approval process by Allenby Capital Limited, which has determined that the Subscription Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, investors should note that: the price of the Subscription Shares may decline and investors could lose all or part of their investment; Subscription Shares offer no guaranteed income and no capital protection; and an investment in Subscription Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Subscription. Furthermore, it is noted that, notwithstanding the Target Market Assessment, only investors who have met the criteria of professional clients and eligible counterparties have been procured. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to Subscription Shares.

 

-ends-

 

Enquiries:  

 

Starcom Plc

 

Michael Rosenberg, Chairman

07785 727 595

Avi Hartmann, CEO 

+972 5447 5663

 

 

Allenby Capital Limited (Nominated Adviser and Broker)

020 3328 5656

James Reeve / Jeremy Porter / Asha Chotai 

 

 

Peterhouse Capital Limited (Joint Broker)

020 7469 0930

Lucy Williams / Charles Goodfellow / Eran Zucker 

 

 

Leander PR (Financial PR)

07795 168 157

Christian Taylor-Wilkinson

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBRGDSUUBBGCR
Date   Source Headline
1st Oct 20217:00 amRNSConversion of loans and Director shareholdings
27th Aug 20217:00 amRNSInterim Results
15th Jul 20212:05 pmRNSSecond Price Monitoring Extn
15th Jul 20212:00 pmRNSPrice Monitoring Extension
15th Jul 20211:29 pmRNSResult of AGM and grant of options
15th Jul 202111:00 amRNSAGM Statement
7th Jul 20217:08 amRNSLokies trial with DHL
23rd Jun 202111:11 amRNSNotice of AGM and proposed grant of options
18th Jun 202110:44 amRNSLokies achieves first place in DHL Challenge
28th May 20215:00 pmRNSTotal Voting Rights
26th May 20217:00 amRNSDirector/PDMR Shareholding
24th May 202111:48 amRNSDirector/PDMR Shareholdings, issue of equity & TVR
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
25th Mar 20217:00 amRNSFinal Results
10th Feb 20217:00 amRNSYear End Trading Update
8th Jan 20214:41 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
24th Dec 202011:05 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 20201:30 pmRNSNew Loan Facility
9th Dec 20204:41 pmRNSSecond Price Monitoring Extn
9th Dec 20204:35 pmRNSPrice Monitoring Extension
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
4th Dec 20202:05 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
1st Dec 20202:06 pmRNSSecond Price Monitoring Extn
1st Dec 20202:01 pmRNSPrice Monitoring Extension
15th Oct 20208:05 amRNSTrading Update
20th Aug 20207:00 amRNSInterim Results
13th Jul 20203:29 pmRNSResult of AGM
6th Jul 20209:39 amRNSNew Bank Facility
26th Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
28th May 20203:30 pmRNSTotal Voting Rights
15th May 20207:00 amRNSConversion of Director's Deferred Salary
28th Apr 202011:00 amRNSPrice Monitoring Extension
22nd Apr 202012:11 pmRNSTrading Update
25th Mar 20207:00 amRNSLoans from Directors and Grant of Warrants
2nd Mar 20207:00 amRNSFinal Results
19th Feb 20207:00 amRNSNew Agreement with CubeMonk
17th Feb 20207:00 amRNSUpdated Contract with Zero Motorcycles
3rd Feb 20207:00 amRNSTrading Update
12th Dec 20194:26 pmRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSBusiness Update
31st Oct 20197:00 amRNSKylos Air Partner Update
30th Sep 20197:00 amRNSLitigation Update
19th Aug 20191:39 pmRNSDirector/PDMR Shareholding
16th Aug 20191:49 pmRNSDirector/PDMR Shareholding
13th Aug 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.